← Every company
Revance Therapeutics Inc Patents
What Revance Therapeutics Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
RVNC on carbonthat →Filings on file
9
Granted
0
Still pending
9
Filed under
2 names
9 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| COMPOSITIONS AND METHODS OF USING PEPTIDES FOR SKIN REJUVENATIONFiled as REVANCE THERAPEUTICS, INC.2025-12-15DAVID HOLLANDER | pending |
| METHODS OF TREATMENT FOR CERVICAL DYSTONIAA61K 38/4893, A61K 47/645, A61P 21/00, A61K 9/0019, A61K 47/26, A61K 47/42, C07K 14/33, C12N 9/52, C12Y 304/24069Filed as REVANCE THERAPEUTICS, INC.2025-03-24Curtis L. Ruegg | pending |
| METHODS OF USING PEPTIDES FOR SKIN REJUVENATIONFiled as Revance Therapeutics, Inc.2024-12-14David Hollander | pending |
| TRANSMUCOSAL BOTULINUM TOXIN COMPOSITIONS, KITS, AND METHODS FOR TREATING BLADDER DISORDERSA61K 38/4893, A61K 47/6455, A61P 13/06, A61P 13/10, A61K 9/0034, A61K 9/127, A61K 9/19, A61K 47/18, A61K 47/26, C12Y 304/24069Filed as REVANCE THERAPEUTICS, INC.2024-12-08Sunita Babbar | pending |
| METHODS FOR DETERMINING INFLUENCE OF CARRIER PEPTIDE ON THE BINDING OF A THERAPEUTIC PROTEIN TO A CELL MEMBRANEFiled as REVANCE THERAPEUTICS, INC.2024-09-25PRISCILLA TOO | pending |
| TREATMENT WITH BOTULINUM TOXIN IN PATIENTS IN NEED OF A RAPID ONSET COSMETIC EFFECT AND SMOOTHER SKIN APPEARANCEFiled as REVANCE THERAPEUTICS, INC.2024-09-19TODD GROSS | pending |
| SERIAL TREATMENT WITH BOTULINUM TOXIN FOR CERVICAL DYSTONIAFiled as REVANCE THERAPEUTICS, INC.2024-09-16TODD GROSS | pending |
| INJECTABLE BOTULINUM TOXIN FORMULATIONS AND METHODS OF USE THEREOF HAVING HIGH RESPONSE RATE AND LONG EFFECT DURATIONA61K 9/0019, A61K 38/4893, A61K 47/645, A61P 17/00, A61K 8/60, A61K 8/64, A61K 8/66, A61K 8/99, A61K 47/26, A61K 47/34, A61K2800/56, A61Q 19/08, C12Y 304/24069Filed as REVANCE THERAPEUTICS, INC.2024-03-04Roman Rubio | pending |
| Albumin-Free Botulinum Toxin FormulationsA61K 38/4893, Y02A 50/30, A61K 8/022, A61K 8/4946, A61K 8/4973, A61K 8/4993, A61K 8/60, A61K 8/602, A61K 8/64, A61K 8/66, A61K 8/84, A61K 8/90, A61K 9/14, A61K 9/19, A61K 39/08, A61K 47/22, A61K 47/26, A61K 47/34, A61K 47/42, A61Q 19/008, A61Q 19/08, C07K 14/33, C12Y 304/24069Filed as REVANCE THERAPEUTICS, INC.2024-01-16Stewart A. Thompson | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.